Date:
24^th March 2015

Venue:
Education Centre (Dept 17), The Christie NHS Foundation Trust, Manchester

Course description:

Delivered by: Elaine Vickers PhD, an expert speaker on targeted cancer therapies and Director of Science Communicated Ltd.

This one day course covers cellular classification and molecular makeup of breast and ovarian cancers. It provides an overview of the targeted treatments in use and under development for breast and ovarian cancers, describing the drugs at a molecular level and their particular relevance and proposed mechanism of action.

Learning ouctomes:

• To build on existing knowledge of molecular pathology.
• Gain greater knowledge of targeted treatments used in breast and ovarian cancers.
• To equip delegates with knowledge that they will be able to apply in practice when discussing trials and targeted treatments with patients.
• Greater understanding of the changing treatments for patients with breast and ovarian malignancies.
• To gain an understanding of the unique genetic features of breast and ovarian cancers.

Topics include:

• Growth pathways and the treatments that target them.
• Novel targets and treatments.
• Logical combinations of targeted treatments.
• Novel agents for chemo-resistant disease.
• Molecular pathologies.

Targeted audience:

This is an advanced course designed for senior nurses and experienced clinical trials staff working in the field of breast and ovarian cancer. Delegates need to have some prior understanding of gene regulation, cell communication and standard breast and ovarian cancer treatments.

Fees:

Delegate fee: £100.00
Early Bird: £75.00 (if booked before 24th January 2015).